Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 lysine 27 trimethylation

[1]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[2]  Yan Liu,et al.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.

[3]  Sarah Filippi,et al.  Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21 , 2012, Proceedings of the National Academy of Sciences.

[4]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[5]  John M. Ashton,et al.  Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. , 2012, Cell stem cell.

[6]  Christopher J. Schofield,et al.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response , 2012, Nature.

[7]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[8]  Jacob D. Jaffe,et al.  Quantitative Assessment of Chromatin Immunoprecipitation Grade Antibodies Directed against Histone Modifications Reveals Patterns of Co-occurring Marks on Histone Protein Molecules* , 2012, Molecular & Cellular Proteomics.

[9]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[10]  Dustin E. Schones,et al.  The Chromatin-binding Protein HMGN1 Regulates the Expression of Methyl CpG-binding Protein 2 (MECP2) and Affects the Behavior of Mice* , 2011, The Journal of Biological Chemistry.

[11]  Syed Haider,et al.  Ensembl BioMarts: a hub for data retrieval across taxonomic space , 2011, Database J. Biol. Databases Curation.

[12]  D. Weinstock,et al.  Repair at Single Targeted DNA Double-Strand Breaks in Pluripotent and Differentiated Human Cells , 2011, PloS one.

[13]  R. Reeves,et al.  Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome. , 2011, Cancer research.

[14]  Michael Bustin,et al.  Effects of HMGN variants on the cellular transcription profile , 2011, Nucleic acids research.

[15]  Clifford A. Meyer,et al.  Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. , 2010, Developmental cell.

[16]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[17]  Trey Ideker,et al.  A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates the B cell fate , 2010, Nature Immunology.

[18]  S. Richards,et al.  Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. , 2010, The Lancet. Oncology.

[19]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[20]  E. Domany,et al.  Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. , 2010, Blood.

[21]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[22]  E. Domany,et al.  Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. , 2010, Blood.

[23]  P. D. Dal Cin,et al.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia , 2009, Proceedings of the National Academy of Sciences.

[24]  J. Downing,et al.  Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia , 2009, Nature Genetics.

[25]  D. C. Cabelof,et al.  Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. , 2009, Blood.

[26]  Takashi Akasaka,et al.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. , 2009, Blood.

[27]  N. Heisterkamp,et al.  Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function , 2009, The Journal of experimental medicine.

[28]  J. T. Kadonaga,et al.  HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility. , 2009, Molecular cell.

[29]  M. Loh,et al.  JAK mutations in high-risk childhood acute lymphoblastic leukemia , 2009, Proceedings of the National Academy of Sciences.

[30]  J. Whitlock,et al.  Malignancy in children with trisomy 21. , 2009, The oncologist.

[31]  R. Foà,et al.  Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. , 2008, Blood.

[32]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[33]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[34]  R. Pedersen,et al.  Robust, Persistent Transgene Expression in Human Embryonic Stem Cells Is Achieved with AAVS1‐Targeted Integration , 2008, Stem cells.

[35]  M. Robinson,et al.  Small-sample estimation of negative binomial dispersion, with applications to SAGE data. , 2007, Biostatistics.

[36]  Mark D. Robinson,et al.  Moderated statistical tests for assessing differences in tag abundance , 2007, Bioinform..

[37]  T. Mikkelsen,et al.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.

[38]  S. Raimondi,et al.  Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia , 2007, Genes, chromosomes & cancer.

[39]  R. A. Etten,et al.  Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells , 2006, Nature Medicine.

[40]  Jun Song,et al.  CEAS: cis-regulatory element annotation system , 2006, Nucleic Acids Res..

[41]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[42]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[43]  D. Weinstock,et al.  Alternative Pathways for the Repair of RAG-Induced DNA Breaks , 2006, Molecular and Cellular Biology.

[44]  D. Weinstock,et al.  Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. , 2006, Methods in enzymology.

[45]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[46]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Bustin,et al.  Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3 , 2005, The EMBO journal.

[48]  C. Bloomfield,et al.  Additional cytogenetic abnormalities in adults with Philadelphia chromosome‐positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B , 2004, British journal of haematology.

[49]  Michael Bustin,et al.  Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin , 2003, The EMBO journal.

[50]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[51]  T. Misteli,et al.  Competition between histone H1 and HMGN proteins for chromatin binding sites , 2002, EMBO reports.

[52]  M. Oshimura,et al.  Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice , 1997, Nature Genetics.

[53]  R. Reeves,et al.  Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. , 1995, DNA and cell biology.

[54]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[55]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[56]  J D Kemp,et al.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow , 1991, The Journal of experimental medicine.

[57]  M. Bustin,et al.  Immunochemical analysis of the exposure of high mobility group protein 14 and 17 surfaces in chromatin. , 1990, The Journal of biological chemistry.

[58]  F. Alt,et al.  IgH enhancer‐mediated deregulation of N‐myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c‐myc expression. , 1989, The EMBO journal.

[59]  J. McPherson,et al.  A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes , 2022 .